Overview

A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott